US equities |
MU $1,088.61 ▲+4.12% SNDK $1,728.20 ▲+4.08% NVDA $237.22 ▼-0.85% AMD $645.14 ▼-0.66% SPCX $167.40 ▼-2.63% INTC $113.11 ▲+0.54% TSLA $376.19 ▼-1.18% AAPL $336.66 ▲+0.91%
FinancialContent

Latest News about Shankar Musunuri

Recent news which mentions Shankar Musunuri

Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
Tickers INNO
Tags Antony Koblish Jeff Aronin Harmony Biosciences Holdings Inc/
From Business Journals
Ocugen's efforts to bring Covid-19 vaccine Covaxin to U.S. boosted by positive study results in children
Tags Shankar Musunuri Pharmaceuticals Ocugen Inc/
From Business Journals
Ocugen to resume Covaxin trials 'immediately' after FDA lifts its latest clinical hold
Tags Shankar Musunuri Pharmaceuticals Health Care
From Business Journals
Ocugen gets rights to Mexico in expanded Covaxin deal with Bharat Biotech
Tags Ocugen Inc/ Pharmaceuticals Biotech
From Business Journals
Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
Tickers INNO
Tags Biocoat Venture capital Biotech
From Business Journals
FDA lifts clinical hold on Ocugen's Covid-19 vaccine study; stock skyrockets
Tags Biotech Insurance Health Care
From Business Journals
Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant
Tags Shankar Musunuri Coronavirus Health Care
From Business Journals
Ocugen applies for emergency FDA authorization for use of its Covid-19 vaccine in children
Tags Shankar Musunuri Ocugen Biotech
From Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
Tickers INNO
Tags Shankar Musunuri OptiNose Inc/ Craig Fraser
From Business Journals